Phenotypic and genotypic comparison of epidemic and non-epidemic strains of pseudomonas aeruginosa from individuals with cystic fibrosis

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Duong, Jessica ^a   Booth, Sean C ^a   McCartney, Nathan K ^a   Rabin, Harvey R ^b   Parkins, Michael D ^a,b   Storey, Douglas G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; MEROPENEM; TOBRAMYCIN; ANTIINFECTIVE AGENT; PRIMER DNA;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOFILM; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG EFFECT; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; BIOMASS; CANADA; CLUSTER ANALYSIS; GENETIC ASSOCIATION STUDY; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY; PHENOTYPE; PSEUDOMONAS INFECTIONS; STATISTICAL MODEL; VIRULENCE;

ADULT; ANTI-BACTERIAL AGENTS; BIOFILMS; BIOMASS; CANADA; CLUSTER ANALYSIS; CYSTIC FIBROSIS; DNA PRIMERS; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, STATISTICAL; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE;

EID: 84957899333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143466     Document Type: Article

References (60)

1. Fitz Simmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993;122(1):1-9. PMID: 8419592
2. Waters V, Stanojevic S, Atenafu EG, Lu A, Yau Y, Tullis E, et al. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J. 2012;40(1):61-66. doi: 10.1183/09031936.00159111 PMID: 22135280
3. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15(2):194-222. PMID: 11932230
4. Dettman JR, Rodrigue N, Aaron SD, Kassen R. Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa. PNAS. 2013;110(52):21065-21070. doi: 10.1073/pnas. 1307862110 PMID: 24324153
5. Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol. 2004;53(7):609-615.
6. Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J. 2012;40(1):227-238. doi: 10.1183/09031936.00204411 PMID: 22323572
7. Pedersen SS, Koch C, Hoiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosain a cystic fibrosis centre. J Antimicrob Chemother. 1986;17(4):505-516. PMID: 3086274
8. Yang L, Jelsbak L, Marvig RL, Damkiær S, Workman CT, Rau MH, et al. Evolutionary dynamics of bacteria in a human host environment. PNAS. 2011;108(18):7481-7486. doi: 10.1073/pnas.1018249108 PMID: 21518885
9. Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, et al. Spread of beta-lactamresistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 1996;348(9028):639-642. PMID: 8782753
10. Jones AM, Govan JRW, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet. 2001;358(9281):557-558. PMID: 11520529
11. Chambers D, Scott F, Bangur R, Davies R, Lim A, Walters S, et al. Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis. Eur Respir J. 2005;26(4):651-656. PMID: 16204596
12. Armstrong DS. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med. 2002;166(7):983-987. PMID: 12359658
13. O'Carroll MR, Syrmis MW, Wainwright CE, Greer RM, Mitchell P, Coulter C, et al. Clonal strains of Pseudomonas aeruginosain paediatric and adult cystic fibrosis units. Eur Respir J. 2004;24(1):101-106. PMID: 15293611
14. Bradbury R, Champion A, Reid DW. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Respirology. 2008;13(6):886-892. doi: 10.1111/j.1440-1843.2008.01383.x PMID: 18811887
15. Luna RA, Millecker LA, Webb CR, Mason SK, Whaley EM, Starke JR, et al. Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. J Clin Microbiol. 2013;51(4):1237-1240. doi: 10.1128/JCM.02157-12 PMID: 23303498
16. Aaron SD, Vandemheen KL, Ramotar K, Giesbrecht-lewis T, Tullis E, Freitag A, et al. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA. 2010;304(19):2145-2153. doi: 10.1001/jama.2010.1665 PMID: 21081727
17. Parkins MD, Glezerson BA, Sibley CD, Sibley KA, Duong J, Purighalla S, et al. A twenty-five year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: Identification of the Prairie Epidemic Strain. J Clin Microbiol. 2014;52(4):1127-1135. doi: 10.1128/JCM.03218-13 PMID: 24452167
18. Somayaji R, Lam J, Surette M, Waddell B, Purighalla S, Sibley C, et al. Clinical outcomes of chronic "Prairie Epidemic Strain" Pseudomonas aeruginosa infection in adults with cystic fibrosis. 38th Annu Eur Cyst Fibros Soc Conf Brussels, Belgium. 2015. Abstract.
19. Poonja A, Workentine M, Waddell B, Surette MG, Duong J, Storey DG, et al. Development and validation of a pcr assay to detect the Prairie Epidemic Strain (PES) of Pseudomonas aeruginosa. 29th Annu North Am Cyst Fibros Conf Pheonix, Arizona, USA. 2015. Abstract.
20. Bodey GP, Bolivar R, Fainstein V, Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis. 1983;5(2):279-313. PMID: 6405475
21. Lonon MK, Woods DE, Straus DC. Production of lipase by clinical isolates of Pseudomonas cepacia. J Clincal Microbiol. 1988;26(5):979-984.
22. Köhler T, Curty LK, Barja F, Delden C Van, Pechère J. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol. 2000;182(21):5990-5996. PMID: 11029417
23. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42(12):5644-5649. PMID: 15583294
24. Beaudoin T, Aaron SD, Giesbrecht-lewis T, Vandemheen K, Mah T. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada. Can J Microbiol. 2010;56(7):548-557. doi: 10.1139/w10-043 PMID: 20651854
25. Korbie DJ, Mattick JS. Touchdown PCR for increased specificity and sensitivity in PCR amplification. Nat Protoc. 2008;3(9):1452-1456. doi: 10.1038/nprot.2008.133 PMID: 18772872
26. Jolley KA, Maiden MCJ. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010;11(1):595.
27. Sokol PA, Ohman DE, Iglewski BH. A more sensitive plate assay for detection of protease production by Pseudomonas aeruginosa. J Clin Microbiol. 1979;9(4):538-540. PMID: 110831
28. Rust L, Messing CR, Iglewski BH. Elastase assays. Methods Enzymol. 1994;235:554-562. PMID: 8057926
29. Murray TS, Kazmierczak BI. FlhF is required for swimming and swarming in Pseudomonas aeruginosa. J Bacteriol. 2006;188(19):6995-7004. PMID: 16980502
30. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37(6):1771-1776. PMID: 10325322
31. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493-496. PMID: 5325707
32. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. 2015;1-77.
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289-300.
34. Kidd TJ, Grimwood K, Ramsay KA, Rainey PB, Bell SC. Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J Clin Microbiol. 2011;49(1):263-268. doi: 10.1128/JCM.01421-10 PMID: 21084517
35. Waine DJ, Honeybourne D, Smith EG, Whitehouse JL, Dowson CG. Cross-sectional and longitudinal multilocus sequence typing of Pseudomonas aeruginosa in cystic fibrosis sputum samples. J Clin Microbiol. 2009;47(11):3444-3448. doi: 10.1128/JCM.00459-09 PMID: 19710263
36. Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC, Rainey PB. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLOS One. 2012;7(9):1-14.
37. Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, et al. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J. 2013;41(5):1091-1100. doi: 10.1183/09031936.00060512 PMID: 22878877
38. Römling U, Fiedler B, Bosshammer J, Grothues D, Greipel J, von der Hardt H, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis. 1994;170(6):1616-1621. PMID: 7996008
39. Vu-Thien H, Corbineau G, Hormigos K, Fauroux B, Corvol H, Clément A, et al. Multiple-locus variablenumber tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients. J Clin Microbiol. 2007;45(10):3175-3183. PMID: 17699654
40. Lelong E, Marchetti A, Simon M, Burns JL, Delden Cvan, Kohler T, et al. Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model. Clin Microbiol Infect. 2011;17(9):1415-1420. doi: 10.1111/j.1469-0691.2010.03431.x PMID: 21091830
41. Manos J, Hu H, Rose BR, Wainwright CE, Zablotska IB, Cheney J, et al. Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2013;32(12):1583-1592. doi: 10.1007/s10096-013-1916-7 PMID: 23832143
42. Woods DE, Sokol PA, Bryan LE, Storey DG, Mattingly SJ, Vogel HJ, et al. In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J Infect Dis. 1991;163(1):143-149. PMID: 1824596
43. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature. 2000;407(6805):762-764. PMID: 11048725
44. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science. 2011;334(6058):982-986. doi: 10.1126/science.1211037 PMID: 22096200
45. Martin DW, Schurr MJ, Mudd MH, Govan JRW, Holloway BW, Deretic V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. PNAS. 1993;90(18):8377-8381. PMID: 8378309
46. Stapper AP. Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation. J Med Microbiol. 2004;53(7):679-690.
47. Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. CurrOpin Microbiol. 2007;10(6):644-648. PMID: 17981495
48. Pedersen SS, Høiby N, Espersen F, Koch C. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax. 1992;47(1):6-13. PMID: 1539148
49. Lam JC, Somayaji R, Surette MG, Rabin HR, Parkins MD. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response. BMC Infect Dis. 2015;15(1):1-12.
50. Parkins MD, Rendall JC, Elborn JS. Incidence and riskfactors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. Chest. 2012;141(2):485-493. doi: 10.1378/chest.11-0917 PMID: 21835906
51. McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet. 2001;358(9281):558-560. PMID: 11520530
52. Al-Aloul M. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax. 2004;59(4):334-336. PMID: 15047956
53. Storey DG, Ujack EE, Rabin HR, Mitchell I. Pseudomonas aeruginosa lasR transcription correlates with the transcription of lasA, lasB, and toxA in chronic lung infections associated with cystic fibrosis. Infect Immun. 1998;66(6):2521-2528. PMID: 9596711
54. Armstrong DS, Hook SM, Jamsen KM, Nixon GM, Carzino R, Carlin JB, et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol. 2005;40(6):500-510. PMID: 16208679
55. Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, Parkins MD, et al. Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLOS One. 2013;8(4):e60225. doi: 10.1371/journal.pone.0060225 PMID: 23573242
56. Foweraker JE, Laughton CR, Brown DFJ, Bilton D. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J Antimicrob Chemother. 2005;55(6):921-927. PMID: 15883175
57. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J RespirCritCare Med. 2011;183(12):1674-1679. doi: 10.1164/rccm.201009-1430OC PMID: 21297072
58. Denning GM, Railsback MA, Rasmussen GT, Cox CD, Britigan BE. Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. Am J Physiol. 1998;274(6):893-900.
59. Konings AF, Martin LW, Sharples KJ, Roddam LF, Latham R, Reid DW, et al. Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun. 2013;81(8):2697-2704. doi: 10.1128/IAI.00418-13 PMID: 23690396
60. Mulcahy H, Charron-Mazenod L, Lewenza S. Pseudomonas aeruginosa produces an extracellular deoxyribonuclease that is required for utilization of DNA as a nutrient source. Environ Microbiol. 2010;12(6):1621-1629. doi: 10.1111/j.1462-2920.2010.02208.x PMID: 20370819